US Edition
#BriaCell Therapeutics to Present Breakthrough Clinical Data at ESMO Congress 2025,
Summary by csimarket.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
#BriaCell Therapeutics to Present Breakthrough Clinical Data at ESMO Congress 2025,
'BriaCell Therapeutics Corp. to Present Clinical Data at ESMO Congress 2025' BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ; TSX: BCT), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, has announced plans to present two clinical data poster presentations at the European Society for Medical Oncology (ESMO) Congress 2025. The annual meeting is scheduled to take place from October 17-21 in B…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
